Literature DB >> 31596126

The prognostic value of faciogenital dysplasias as biomarkers in head and neck squamous cell carcinoma.

Chao Ma1, Haoyu Li2, Xian Li3, Shuwen Lu4, Jianfeng He1.   

Abstract

Aim: This present study aims to investigate the prognostic value of FGD genes for predicting the overall survival in head and neck squamous cell carcinoma (HNSC) patients. Materials & methods: Clinical information and FGD gene expressions of 513 HNSC patients were obtained from The Cancer Genome Atlas dataset. Kaplan-Meier survival, Pearson correlation coefficient analyses and enrichment analyses were performed based on The Cancer Genome Atlas dataset, as well as FGD gene expressions analysis in normal tissues.
Results: The survival analyses showed that high levels of FGD2 and FGD3 mRNA expressions, and the combination of high levels of FGD2 and FGD3 mRNAs were associated with the favorable overall survival in HNSC patients (p < 0.01). Oppositely, no significant correlations (p > 0.05) were observed between gender and race and OS.
Conclusion: Our findings suggest that the expression levels of FGD2 and FGD3 mRNAs in HNSC are associated with favorable prognosis and may be regarded as potential prognostic biomarkers.

Entities:  

Keywords:  TCGA; biomarker; diagnosis; head and neck squamous cell carcinoma; mRNA; prognosis

Mesh:

Substances:

Year:  2019        PMID: 31596126     DOI: 10.2217/bmm-2019-0273

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  2 in total

1.  FGD3 binds with HSF4 to suppress p65 expression and inhibit pancreatic cancer progression.

Authors:  Feng Guo; Xiang Cheng; Boping Jing; Heshui Wu; Xin Jin
Journal:  Oncogene       Date:  2022-01-03       Impact factor: 9.867

2.  Immune Score Indicator for the Survival of Melanoma Patients Based on Tumor Microenvironment.

Authors:  Xuchao Ning; Renzhi Li; Bin Zhang; Yue Wang; Ziyi Zhou; Zanzan Ji; Xiajie Lyu; Zhenyu Chen
Journal:  Int J Gen Med       Date:  2021-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.